StockStory.org on MSN
PacBio earnings: What to look for from PACB
Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results this Thursday after ...
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Pacific Biosciences. Analysts have given Pacific ...
PacBio received $48.1 million in net cash proceeds from the transaction. Under the terms of the agreement, Illumina assumed certain liabilities and granted a non-exclusive license certain intellectual ...
2d
How The Narrative Around Pacific Biosciences Of California (PACB) Is Shifting As Assumptions Evolve
Fine tuning the fair value story Analysts covering Pacific Biosciences of California have kept their fair value anchor essentially steady at about US$2.42 per share, while making small tweaks to the ...
In the most recent trading session, Pacific Biosciences of California (PACB) closed at $2.26, indicating a -4.64% shift from ...
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, delivered an adjusted loss per share of 13 cents in second-quarter 2025, narrower than the year-ago adjusted loss of 20 cents ...
Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.
(RTTNews) - PacBio (PACB), a developer of highly accurate sequencing solutions, is slated to participate in several upcoming investor conferences this month, underscoring its visibility within the ...
MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced plans to pursue a strategic collaboration ...
Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results